285 related articles for article (PubMed ID: 2535718)
1. Structural and functional characterization of human immunodeficiency virus tat protein.
Ruben S; Perkins A; Purcell R; Joung K; Sia R; Burghoff R; Haseltine WA; Rosen CA
J Virol; 1989 Jan; 63(1):1-8. PubMed ID: 2535718
[TBL] [Abstract][Full Text] [Related]
2. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
[TBL] [Abstract][Full Text] [Related]
3. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
Kuppuswamy M; Subramanian T; Srinivasan A; Chinnadurai G
Nucleic Acids Res; 1989 May; 17(9):3551-61. PubMed ID: 2542902
[TBL] [Abstract][Full Text] [Related]
4. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
5. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication.
Sadaie MR; Mukhopadhyaya R; Benaissa ZN; Pavlakis GN; Wong-Staal F
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1257-63. PubMed ID: 2078407
[TBL] [Abstract][Full Text] [Related]
6. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
[TBL] [Abstract][Full Text] [Related]
7. Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization.
Siomi H; Shida H; Maki M; Hatanaka M
J Virol; 1990 Apr; 64(4):1803-7. PubMed ID: 2108259
[TBL] [Abstract][Full Text] [Related]
8. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
9. HIV Tat protein requirements for transactivation and repression of transcription are separable.
Brown JA; Howcroft TK; Singer DS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jan; 17(1):9-16. PubMed ID: 9436753
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of the human immunodeficiency virus rev protein.
Perkins A; Cochrane AW; Ruben SM; Rosen CA
J Acquir Immune Defic Syndr (1988); 1989; 2(3):256-63. PubMed ID: 2656990
[TBL] [Abstract][Full Text] [Related]
11. Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1.
Viglianti GA; Mullins JI
J Virol; 1988 Dec; 62(12):4523-32. PubMed ID: 2846868
[TBL] [Abstract][Full Text] [Related]
12. Role of the cysteine-rich region of HIV tat protein on its trans-activational ability.
Kubota S; Endo S; Maki M; Hatanaka M
Virus Genes; 1989 Mar; 2(2):113-8. PubMed ID: 2541558
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between the HIV transactivator Tat and the transcriptional coactivator PC4 in T cells.
Holloway AF; Occhiodoro F; Mittler G; Meisterernst M; Shannon MF
J Biol Chem; 2000 Jul; 275(28):21668-77. PubMed ID: 10887206
[TBL] [Abstract][Full Text] [Related]
14. Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins.
Dang CV; Lee WM
J Biol Chem; 1989 Oct; 264(30):18019-23. PubMed ID: 2553699
[TBL] [Abstract][Full Text] [Related]
15. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein.
Rice AP; Carlotti F
J Virol; 1990 Apr; 64(4):1864-8. PubMed ID: 2181156
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
Arya SK
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
[TBL] [Abstract][Full Text] [Related]
18. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator.
Kamine J; Elangovan B; Subramanian T; Coleman D; Chinnadurai G
Virology; 1996 Feb; 216(2):357-66. PubMed ID: 8607265
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.
Orsini MJ; Debouck CM
J Virol; 1996 Nov; 70(11):8055-63. PubMed ID: 8892930
[TBL] [Abstract][Full Text] [Related]
20. Intracellular trafficking and interactions of the HIV-1 Tat protein.
Stauber RH; Pavlakis GN
Virology; 1998 Dec; 252(1):126-36. PubMed ID: 9875323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
